Transcriptomics

Dataset Information

0

HMGN5 escorts oncogenic STAT3 signaling by regulating chromatin landscape in tumorigenesis of breast cancer


ABSTRACT: Epigenetic alterations are widely linked with carcinogenesis, therefore becoming emerging therapeutic targets in the treatment of cancers, including breast cancer. HMGNs are nucleosome binding proteins, which regulate chromatin structures in a cell type- and disease-specific manner. However, the roles of HMGNs in the tumorigenesis of breast cancer are less known. In this study, we report that HMGNs are highly expressed in 3D-cultured breast cancer cells. HMGN5, a member of HMGNs, controls the proliferation, invasion and metastasis of breast cancer cells in vitro and in vivo. Clinically, HMGN5 is an unfavorable prognostic marker in patients. Mechanistically, HMGN5 is governed by active STAT3 transcriptionally and further escorts STAT3 to shape oncogenic chromatin landscape and transcriptional program. Lastly, we provide evidence that interference of HMGN5 by nanoparticle-packaged siRNA is potentially an effective approach in breast cancer treatment. Taken together, our findings reveal a novel feed-forward circuit between HMGN5 and STAT3 in promoting breast cancer tumorigenesis and suggest HMGN5 as a novel epigenetic therapeutic target in STAT3-hyperactive breast cancer.

ORGANISM(S): Homo sapiens

PROVIDER: GSE193507 | GEO | 2022/08/31

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

| PRJNA796499 | ENA
2014-11-22 | E-GEOD-63530 | biostudies-arrayexpress
2024-05-08 | GSE166101 | GEO
2024-05-08 | GSE166091 | GEO
2024-05-08 | GSE166098 | GEO
2024-05-08 | GSE166103 | GEO
2014-11-22 | GSE63530 | GEO
2010-11-04 | GSE24124 | GEO
2015-04-17 | PXD001070 | Pride
2011-12-22 | E-GEOD-20597 | biostudies-arrayexpress